RE-COLLAGEN® by Promopharma ABOUT THE PRODUCT
RE-COLLAGEN® is an advanced nutritional supplement in liquid form, designed to support skin, joints, bones, and connective tissue health from within. Developed by the renowned Italian pharmaceutical company Promopharma, known for its high-quality aesthetic medicine products.
KEY INGREDIENTS
- Hydrolysed Marine Collagen (5000 mg) – high bioavailability, type I collagen peptides for skin, hair, and nails;
- Hyaluronic Acid (80 mg) – deep hydration, joint lubrication, skin plumping;
- Vitamin C (80 mg) – essential for collagen synthesis, antioxidant protection;
- Vitamin E (12 mg) – protects cells from oxidative stress;
- Biotin (Vitamin B7) (50 μg) – supports healthy skin, hair, and nails;
- Zinc (10 mg) – aids tissue repair, supports immune function;
- Coenzyme Q10 (10 mg) – cellular energy production, anti-ageing.
INDICATIONS
- Prevention and correction of age-related skin changes;
- Improvement of skin elasticity, hydration, and radiance;
- Support for joint and bone health;
- Strengthening of hair and nails;
- Complementary treatment in aesthetic medicine;
- Post-procedure recovery support;
- Active lifestyle and sports support.
HOW TO USE
- Dosage: 1 vial (25 ml) daily
- When: Preferably in the morning on an empty stomach
- Duration: Minimum 3 months for visible results
- Recommended: Regular courses 2–3 times per year
- Taste: Pleasant peach flavour
EXPECTED RESULTS
After 4–12 weeks of regular use:
- Improved skin firmness and elasticity
- Reduction of fine lines and wrinkles
- Enhanced skin hydration and radiance
- Stronger hair and nails
- Improved joint mobility and comfort
- Overall wellness and vitality
WHY CHOOSE RE-COLLAGEN®?
- Pharmaceutical-grade quality by Promopharma (Italy)
- High-dose marine collagen with proven bioavailability
- Comprehensive formula with synergistic ingredients
- Liquid form for optimal absorption
- Pleasant taste, easy to take
- Suitable for daily use
Available at our clinic. Consult our specialists for personalised recommendations.
